Results 181 to 190 of about 65,592 (243)

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma [PDF]

, 2018
Brochez, Lieve, CHEVOLET, INES, Kruse, Vibeke, Meireson, Annabel, Ost, Piet, Sundahl, Nora   +5 more
core   +1 more source

Impact of melanoma histological regression on first‐line immunotherapy response in stage‐IV disease

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page e342-e345, May 2026.
Jean‐Baptiste Such, Sandrine Mansard, Mélissa Zlobecki, Carole Chevenet, Céline Lambert, Marie Bachelerie, Jacques Rouanet   +6 more
wiley   +1 more source

Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives. [PDF]

BMJ Oncol
Storandt MH, Sinicrope FA.
europepmc   +1 more source

The Emerging Melanoma Management: Historical Perspective to Future Directions. [PDF]

Cancers (Basel)
Hui SY, Jain R, Haass NK, Weninger W, Tikoo S, Guo D.   +5 more
europepmc   +1 more source

Neurotoxicity of immune checkpoint inhibitors: a retrospective pharmacovigilance study using FAERS database. [PDF]

Front Immunol
Cao L, Wang Y, Dai P, Li X.
europepmc   +1 more source

Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-Response. [PDF]

, 2020
Chae, Young Kwang, Kurzrock, Razelle, Othus, Megan, Patel, Sandip P, S1609 Team   +4 more
core  

Impact of immune checkpoint inhibition on ovarian reserve. [PDF]

Oncologist
Buchbinder EI, Song Z, Cohen JV, Lee SJ, Smith KK, Manos M, Tarhini A, Dougan M.   +7 more
europepmc   +1 more source

NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. [PDF]

J Clin Oncol
Morris VK, Ciombor KK, Xiao L, Ochieng JK, Marmonti E, Polite B, Weinberg BA, Krauss JC, Hays J, Mukherjee S, Aranha O, Iqbal S, Shields T, Benson AB, Kazmi S, Lieu C, Hochster H, Whisenant J, Haymaker C, Eng C.   +19 more
europepmc   +1 more source

A fast and efficient strategy for the NMR assignment of Fab methyl groups. [PDF]

J Biomol NMR
Henot F, Vibert B, Giraud A, Dbira S, Imbert L, Favier A, Güntert P, Clavier S, Crublet E, Doyen C, Boisbouvier J, Frances O.   +11 more
europepmc   +1 more source

Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer. [PDF]

Ther Adv Med Oncol
Qadri F, Afghan MK, Lutfi A, Javaid S, Guniganti P, Cardenes H, Pigazzi A, Kasi PM.   +7 more
europepmc   +1 more source